moxifloxacin has been researched along with xanthoangelol in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (xanthoangelol) | Trials (xanthoangelol) | Recent Studies (post-2010) (xanthoangelol) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 51 | 0 | 32 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz, A; Ebrahim, W; Hartmann, R; Kalscheuer, R; Kurtán, T; Lin, W; Liu, Z; Mándi, A; Muharini, R; Orfali, RS; Proksch, P; Rehberg, N | 1 |
| Bandow, JE; Hernández, MV; Kalscheuer, R; Meier, D; Muharini, R; Proksch, P; van Geelen, L | 1 |
2 other study(ies) available for moxifloxacin and xanthoangelol
| Article | Year |
|---|---|
Antibacterial and Cytotoxic Phenolic Metabolites from the Fruits of Amorpha fruticosa.
Topics: Animals; Anti-Bacterial Agents; Fabaceae; Fruit; Inhibitory Concentration 50; Isoflavones; Lymphoma; Mice; Molecular Structure; Phenols; Plant Extracts | 2017 |
The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Cell Line; Chalcone; Fabaceae; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2019 |